Cravath represented the underwriters in the offering.
Albemarle Corporation represented the $1.4 billion registered secondary common stock offering. The shares were listed on the New York Stock Exchange. The transaction closed on February 8, 2021.
J.P. Morgan Securities LLC, BofA Securities, Inc., HSBC Securities (USA) Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc., BTIG, LLC, Santander Investment Securities Inc., Truist Securities, Inc., Goldman Sachs & Co. LLC, and Siebert Williams Shank & Co., LLC acted as underwriters for the offering.
Albemarle Corporation is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals across end markets including petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services.
The Cravath team advising the underwriters included partners William V. Fogg (Picture) and Michael E. Mariani and associates Steven Y. Li and Zoe E. Egelman on capital markets matters, and partner Christopher K. Fargo and associates Rory M. Minnis and Carlos Nicholas Obando on tax matters.
Involved fees earner: Zoe Egelman – Cravath Swaine & Moore; Christopher K. Fargo – Cravath Swaine & Moore; William Fogg – Cravath Swaine & Moore; Steven Li – Cravath Swaine & Moore; Michael Mariani – Cravath Swaine & Moore; Rory Minnis – Cravath Swaine & Moore; Carlos Nicholas Obando – Cravath Swaine & Moore;
Law Firms: Cravath Swaine & Moore;
Clients: Bank of America Securities; BTIG, LLC; Goldman Sachs & Co.; HSBC Securities; J.P. Morgan Securities LLC; Mizuho Securities; MUFG Securities Americas Inc. ; Santander Investment Securities Inc.; Siebert Williams Shank & Co. LLC; SMBC Nikko Securities America; Truist Securities Inc. ;